Northstar Healthcare Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Northstar Healthcare Pharmaceutical Import Records from India — 3 Products, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Northstar Healthcare — Pharmaceutical Importer Profile (2026) | 3 Products, $2.0M Trade | TransData Nexus

Northstar Healthcare

Pharmaceutical Importer · United States · CNS & Psychiatric Focus · $2.0M Total Trade · DGFT Verified

Northstar Healthcare is a pharmaceutical importer based in United States with a total trade value of $2.0M across 3 products in 2 therapeutic categories. Based on 41 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Northstar Healthcare sources from 7 verified Indian suppliers, with Aurobindo Pharma Limited accounting for 70.3% of imports.

Northstar Healthcare — Import Portfolio & Supplier Network

Northstar Healthcare import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Northstar Healthcare?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Limited	$10.7M	499	70.3%
Apl Healthcare Limited	$2.7M	82	17.7%
Dr Reddys Laboratories Limited

What Formulations Does Northstar Healthcare Import?

Formulation	Value	Ships
Sertraline hydrochloride tablets 100MG	$1.1M	25
Amoxicillin and clavulanate potassium	$610.8K	26
Sertraline hydrochloride tablets 50MG	$517.4K	15
Gabapentin capsules 300MG (gabapentin	$450.0K	9
Abiraterone acetate 250mgtab120s ns	$300.0K	6
Sevelamer carbonate tablets 800MG	$263.2K	6
Levetiracetam oral solution 100MG/ML	$254.6K	14
Escitalopram 20 MG tablets (escitalopram20 MG)	$252.4K	11
Valaciclovir tablets 500 MG (valacyclovir tablets 500 MG)	$237.9K	5
Gabapentin capsules 100MG (gabapentin	$227.2K	7
Amoxicillin & clavulanate potassium	$200.2K	9
Gabapentin capsules 400MG (gabapentin capsules)	$198.6K	10
Fluoxetine capsules 20MG	$189.9K	7
Gabapentin capsules 400MG (gabapentin capsules)	$164.0K	11
Gabapentin capsules 300MG (gabapentin capsules)	$156.8K	5

Northstar Healthcare imports 302 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sertraline	CNS & Psychiatric	$1.4M	29	0.3%	16
2	Acyclovir	Antivirals	$300.0K	6	0.2%	14
3	Valacyclovir	Antivirals	$300.0K	6	0.3%	10

Northstar Healthcare imports 3 pharmaceutical products across 2 categories into United States totaling $2.0M.

Northstar Healthcare — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Northstar Healthcare is a U.S.-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from international suppliers, particularly from India. The company operates as a buyer, sourcing a diverse range of pharmaceutical products to meet the needs of the U.S. market. While specific details about its headquarters and parent company are not publicly disclosed, Northstar Healthcare plays a significant role in the U.S. pharmaceutical distribution network by facilitating the importation of essential medications.

2Distribution Network

Northstar Healthcare's distribution network encompasses multiple strategic locations across the United States, ensuring efficient logistics and timely delivery of pharmaceutical products. The company collaborates with various distribution centers and partners to maintain a robust supply chain, facilitating the seamless movement of goods from international suppliers to end-users within the U.S. Specific details regarding warehouse locations and logistics capabilities are not publicly available.

3Industry Role

In the U.S. pharmaceutical supply chain, Northstar Healthcare functions primarily as a pharmaceutical importer and buyer. By sourcing finished pharmaceutical formulations from international suppliers, especially from India, the company contributes to the diversification and availability of medications in the U.S. market. This role is crucial in meeting the demand for various pharmaceutical products and ensuring a steady supply to healthcare providers and patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Northstar Healthcare

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Northstar Healthcare's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a single supplier, Aurobindo Pharma Limited. This dependency suggests a strategic choice aimed at leveraging the supplier's capabilities and ensuring a consistent supply of products. However, such concentration also introduces potential risks, including supply chain disruptions and pricing volatility. The stability of this relationship is indicated by the substantial number of shipments and the long-term nature of the partnership, reflecting a mutually beneficial arrangement.

2Supply Chain Resilience

The resilience of Northstar Healthcare's supply chain is bolstered by its partnerships with multiple suppliers, including Aurobindo Pharma Limited, APL Healthcare Limited, and Dr. Reddy's Laboratories Limited. This diversification mitigates risks associated with over-reliance on a single source. The company's focus on finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), allows for greater control over product quality and compliance. While specific details about backup suppliers and shipping routes are not publicly disclosed, the existing supplier base suggests a strategic approach to maintaining supply chain stability.

Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The Federal Food, Drug, and Cosmetic Act (FD&C Act) provides the legal framework governing these activities, ensuring that imported drugs meet standards for quality, safety, and effectiveness. The FDA's regulations require that all drugs offered for importation into the U.S. comply with specific labeling, manufacturing, and testing standards to protect public health.

2Import Licensing & GMP

Importers like Northstar Healthcare must adhere to FDA regulations, which include obtaining necessary import licenses and ensuring that imported pharmaceutical products are manufactured in compliance with Good Manufacturing Practice (GMP) standards. The FDA recognizes GMP certifications from various international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications are essential for ensuring the quality and safety of pharmaceutical products entering the U.S. market.

3Quality & Labeling

Northstar Healthcare — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Northstar Healthcare's focus on importing pharmaceutical products in the Central Nervous System (CNS) & Psychiatric and Antivirals therapeutic categories aligns with market demand for treatments in these areas. The substantial import value of sertraline, a selective serotonin reuptake inhibitor (SSRI), indicates a strategic emphasis on addressing mental health conditions. The inclusion of antiviral medications like acyclovir and valacyclovir reflects a commitment to providing treatments for viral infections, catering to a broad patient population.

2Sourcing Profile

Northstar Healthcare's sourcing strategy centers on finished pharmaceutical formulations, primarily generic drugs, sourced from India. This approach leverages India's robust pharmaceutical manufacturing capabilities and cost advantages. By focusing on finished products, Northstar Healthcare ensures compliance with FDA regulations and maintains control over product quality, facilitating smoother entry into the U.S. market.

3Market Positioning

Based on its product mix, Northstar Healthcare serves the U.S. pharmaceutical market by supplying medications to various segments, including retail pharmacies, hospitals, and healthcare providers. The company's imports of CNS & Psychiatric and Antivirals products suggest a focus on both outpatient and inpatient care, addressing a wide range of therapeutic needs.

Seller's Guide — How to Become a Supplier to Northstar Healthcare

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Northstar Healthcare, especially those offering high-quality, FDA-compliant finished pharmaceutical formulations. Gaps in Northstar Healthcare's current sourcing may exist in areas such as emerging therapeutic categories or specialized formulations. Indian exporters can explore these opportunities by ensuring compliance with FDA regulations and demonstrating the quality and efficacy of their products.

2Requirements & Qualifications

Indian exporters seeking to supply Northstar Healthcare and the U.S. market must obtain GMP certifications recognized by the FDA, such as EU GMP, WHO GMP, or PIC/S. Additionally, they must ensure that their products meet FDA labeling requirements, including English language labeling and inclusion of all necessary information. Compliance with FDA regulations is essential for successful market entry and distribution in the U.S.

3How to Approach

Frequently Asked Questions — Northstar Healthcare

What products does Northstar Healthcare import from India?

Northstar Healthcare imports 3 pharmaceutical products across 2 categories. Top imports: Sertraline ($1.4M), Acyclovir ($300.0K), Valacyclovir ($300.0K).

Who supplies pharmaceuticals to Northstar Healthcare from India?

Northstar Healthcare sources from 7 verified Indian suppliers. The primary supplier is Aurobindo Pharma Limited (70.3% of imports, $10.7M).

What is Northstar Healthcare's total pharmaceutical import value?

Northstar Healthcare's total pharmaceutical import value from India is $2.0M, based on 41 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Northstar Healthcare focus on?

Northstar Healthcare imports across 2 categories. The largest: CNS & Psychiatric (70.7%), Antivirals (29.3%).

Get Full Northstar Healthcare Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.